197 related articles for article (PubMed ID: 26099723)
21. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
22. Novel antitumor activity of the combined treatment of galloylquinic acid compounds with doxorubicin in solid Ehrlich carcinoma model via the Notch signaling pathway modulation.
Abd El-Salam MA; El-Tanbouly GS; Bastos JK; Metwaly HA
Life Sci; 2022 Jun; 299():120497. PubMed ID: 35339508
[TBL] [Abstract][Full Text] [Related]
23. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
El-Dayem SM; Fouda FM; Ali EH; Motelp BA
Toxicol Ind Health; 2013 Jun; 29(5):404-17. PubMed ID: 22317827
[TBL] [Abstract][Full Text] [Related]
24. Polydatin gold nanoparticles potentiate antitumor effect of doxorubicin in Ehrlich ascites carcinoma-bearing mice.
Samra YA; Abdelghany AM; Zaghloul RA
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22869. PubMed ID: 34339076
[TBL] [Abstract][Full Text] [Related]
25. Doxorubicin induced apoptosis was potentiated by neferine in human lung adenocarcima, A549 cells.
Poornima P; Kumar VB; Weng CF; Padma VV
Food Chem Toxicol; 2014 Jun; 68():87-98. PubMed ID: 24632453
[TBL] [Abstract][Full Text] [Related]
26. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
27. Oil rich in carotenoids instead of vitamins C and E as a better option to reduce doxorubicin-induced damage to normal cells of Ehrlich tumor-bearing mice: hematological, toxicological and histopathological evaluations.
Miranda-Vilela AL; Grisolia CK; Longo JPF; Peixoto RCA; de Almeida MC; Barbosa LCP; Roll MM; Portilho FA; Estevanato LLC; Bocca AL; Báo SN; Lacava ZGM
J Nutr Biochem; 2014 Nov; 25(11):1161-1176. PubMed ID: 25127291
[TBL] [Abstract][Full Text] [Related]
28. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor.
Saraswati S; Agrawal SS; Alhaider AA
Chem Biol Interact; 2013 Nov; 206(2):153-65. PubMed ID: 24051192
[TBL] [Abstract][Full Text] [Related]
29. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.
Mookerjee A; Basu JM; Majumder S; Chatterjee S; Panda GS; Dutta P; Pal S; Mukherjee P; Efferth T; Roy S; Choudhuri SK
BMC Cancer; 2006 Nov; 6():267. PubMed ID: 17107616
[TBL] [Abstract][Full Text] [Related]
30. Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy.
Monem AS; Elbialy N; Mohamed N
Int J Pharm; 2014 Aug; 470(1-2):1-7. PubMed ID: 24792973
[TBL] [Abstract][Full Text] [Related]
31. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma.
Alkreathy HM; Alkhatib MH; Al Musaddi SA; Balamash KSA; Osman NN; Ahmad A
Clin Exp Pharmacol Physiol; 2019 May; 46(5):496-505. PubMed ID: 30724380
[TBL] [Abstract][Full Text] [Related]
32. Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice.
Wahab MH; Akoul ES; Abdel-Aziz AA
Tumori; 2000; 86(2):157-62. PubMed ID: 10855855
[TBL] [Abstract][Full Text] [Related]
33. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
34. Hesperidin suppressed metastasis, angiogenesis and tumour growth in Balb/c mice model of breast cancer.
Shakiba E; Bazi A; Ghasemi H; Eshaghi-Gorji R; Mehdipour SA; Nikfar B; Rashidi M; Mirzaei S
J Cell Mol Med; 2023 Sep; 27(18):2756-2769. PubMed ID: 37581480
[TBL] [Abstract][Full Text] [Related]
35. Menadione reduced doxorubicin resistance in Ehrlich ascites carcinoma cells in vitro.
Xu CJ; Zhang Y; Wang J; Zhang TM
Zhongguo Yao Li Xue Bao; 1998 May; 19(3):273-6. PubMed ID: 10375743
[TBL] [Abstract][Full Text] [Related]
36. Euphorbia grantii Oliv. standardized extract and its fraction ameliorate doxorubicin-induced cardiomyopathy in Ehrlich carcinoma bearing mice.
Saber MM; Radi MH; El-Shiekh RA; Abdel-Sattar E; El-Halawany AM
J Ethnopharmacol; 2024 Mar; 321():117566. PubMed ID: 38081395
[TBL] [Abstract][Full Text] [Related]
37. Comparative study between the effect of methotrexate and valproic acid on solid Ehrlich tumour.
Abdel-Rahman MN; Kabel AM
J Egypt Natl Canc Inst; 2012 Dec; 24(4):161-7. PubMed ID: 23159286
[TBL] [Abstract][Full Text] [Related]
38. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
39. Naringenin Ameliorates Doxorubicin Toxicity and Hypoxic Condition in Dalton's Lymphoma Ascites Tumor Mouse Model: Evidence from Electron Paramagnetic Resonance Imaging.
Kathiresan V; Subburaman S; Krishna AV; Natarajan M; Rathinasamy G; Ganesan K; Ramachandran M
J Environ Pathol Toxicol Oncol; 2016; 35(3):249-262. PubMed ID: 27910780
[TBL] [Abstract][Full Text] [Related]
40. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity.
El-Moselhy MA; El-Sheikh AA
Biomed Pharmacother; 2014 Feb; 68(1):101-10. PubMed ID: 24268999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
